Michael Praus

821 total citations
19 papers, 691 citations indexed

About

Michael Praus is a scholar working on Surgery, Molecular Biology and Internal Medicine. According to data from OpenAlex, Michael Praus has authored 19 papers receiving a total of 691 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 6 papers in Molecular Biology and 5 papers in Internal Medicine. Recurrent topics in Michael Praus's work include Blood Coagulation and Thrombosis Mechanisms (5 papers), Venous Thromboembolism Diagnosis and Management (5 papers) and Prion Diseases and Protein Misfolding (4 papers). Michael Praus is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (5 papers), Venous Thromboembolism Diagnosis and Management (5 papers) and Prion Diseases and Protein Misfolding (4 papers). Michael Praus collaborates with scholars based in Germany, United States and Belgium. Michael Praus's co-authors include Robert D. Gerard, D Collen, Andreas Koster, Herman Kuppe, Wolfgang M. Kuebler, Thomas Fischer, H. Haberzettl, Roland Hetzer, Véronique Masson and Norbert E. Fusenig and has published in prestigious journals such as The Journal of Cell Biology, International Journal of Cancer and Anesthesiology.

In The Last Decade

Michael Praus

19 papers receiving 670 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Praus Germany 12 280 273 178 139 106 19 691
Judit Mihaly Austria 6 263 0.9× 337 1.2× 165 0.9× 60 0.4× 83 0.8× 8 663
P Tijburg United States 10 248 0.9× 69 0.3× 223 1.3× 81 0.6× 74 0.7× 13 567
Alexandre C. Zago Brazil 8 188 0.7× 92 0.3× 153 0.9× 123 0.9× 65 0.6× 12 591
Gimbrone Ma United States 7 228 0.8× 78 0.3× 65 0.4× 80 0.6× 85 0.8× 10 538
C Klein-Soyer France 15 239 0.9× 79 0.3× 156 0.9× 64 0.5× 84 0.8× 20 577
Shuchong Pan United States 18 256 0.9× 68 0.2× 132 0.7× 164 1.2× 36 0.3× 33 835
Karim Harhouri France 14 561 2.0× 72 0.3× 54 0.3× 68 0.5× 90 0.8× 19 778
Daniel Yacoub Canada 14 136 0.5× 49 0.2× 190 1.1× 85 0.6× 111 1.0× 20 609
Servé Olieslagers Netherlands 11 210 0.8× 75 0.3× 108 0.6× 80 0.6× 61 0.6× 15 519
Harlan N. Bradford United States 18 203 0.7× 90 0.3× 533 3.0× 29 0.2× 38 0.4× 39 979

Countries citing papers authored by Michael Praus

Since Specialization
Citations

This map shows the geographic impact of Michael Praus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Praus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Praus more than expected).

Fields of papers citing papers by Michael Praus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Praus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Praus. The network helps show where Michael Praus may publish in the future.

Co-authorship network of co-authors of Michael Praus

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Praus. A scholar is included among the top collaborators of Michael Praus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Praus. Michael Praus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Baier, Michael, Hermann−Georg Holzhütter, Eckart Köttgen, et al.. (2004). Both lysine-clusters of the NH2-terminal prion-protein fragment PrP23-110 are essential for t-PA mediated plasminogen activation. Thrombosis and Haemostasis. 91(3). 465–472. 21 indexed citations
2.
Wendeler, Markus W., et al.. (2004). Ksp-cadherin is a functional cell–cell adhesion molecule related to LI-cadherin. Experimental Cell Research. 294(2). 345–355. 27 indexed citations
3.
4.
Schleuning, Wolf‐Dieter, et al.. (2004). Prion protein stimulates tissue‐type plasminogen activator‐mediated plasmin generation via a lysine‐binding site on kringle 2. Journal of Thrombosis and Haemostasis. 2(6). 962–968. 20 indexed citations
5.
Pfeufer, Arne, et al.. (2004). The intron 6 G/T polymorphism of c-myb oncogene and the risk for coronary in-stent restenosis. Basic Research in Cardiology. 99(4). 309–14. 3 indexed citations
6.
Praus, Michael, Michael Baier, Hermann−Georg Holzhütter, et al.. (2003). Stimulation of plasminogen activation by recombinant cellular prion protein is conserved in the NH$_2$-terminal fragment PrP23-110. PubMed. 89(5). 812–9. 27 indexed citations
7.
Praus, Michael, Hermann−Georg Holzhütter, Peter R. Jungblut, et al.. (2003). Stimulation of plasminogen activation by recombinant cellular prion protein is conserved in the NH2-terminal fragment PrP23-110. Thrombosis and Haemostasis. 89(5). 812–819. 25 indexed citations
8.
Praus, Michael, Désiré Collen, & Robert D. Gerard. (2002). Both u‐PA inhibition and vitronectin binding by plasminogen activator inhibitor 1 regulate HT1080 fibrosarcoma cell metastasis. International Journal of Cancer. 102(6). 584–591. 33 indexed citations
9.
Koster, Andreas, et al.. (2002). The Plasma Supplemented Modified Activated Clotting Time for Monitoring of Heparinization During Cardiopulmonary Bypass: A Pilot Investigation. Anesthesia & Analgesia. 95(1). 26–30. 34 indexed citations
10.
Koster, Andreas, Thomas Fischer, Michael Praus, et al.. (2002). Hemostatic Activation and Inflammatory Response during Cardiopulmonary Bypass. Anesthesiology. 97(4). 837–841. 130 indexed citations
11.
Bajou, Khalid, Véronique Masson, Robert D. Gerard, et al.. (2001). The Plasminogen Activator Inhibitor PAI-1 Controls in Vivo Tumor Vascularization by Interaction with Proteases, Not Vitronectin. The Journal of Cell Biology. 152(4). 777–784. 268 indexed citations
12.
Gulba, Dietrich C., Ralf Dechend, Rainer Dietz, Stephan Moll, & Michael Praus. (1999). Thrombolyse - neue Thrombolytika, neue Begleittherapie: Update 1999. Journal für Kardiologie (Krause & Pachernegg GmbH). 6(3). 142–153. 1 indexed citations
13.
Praus, Michael, et al.. (1999). Reduction of tumor cell migration and metastasis by adenoviral gene transfer of plasminogen activator inhibitors. Gene Therapy. 6(2). 227–236. 48 indexed citations
14.
Gulba, Dietrich C., Michael Praus, Ralf Dechend, et al.. (1997). Update on the toxicology and pharmacology of rDSPA alpha 1 (Bat-PA) in animals and humans. Fibrinolysis & proteolysis. 11. 55–62. 7 indexed citations
15.
16.
Gulba, Dietrich C., Michael Praus, & W. Witt. (1995). DSPA alpha — Properties of the plasminogen activators of the vampire bat Desmodus rotundus. Fibrinolysis and Proteolysis. 9. 91–96. 13 indexed citations
17.
Dechend, R, et al.. (1994). How does heparin enhance thrombolysis?. Fibrinolysis and Proteolysis. 8. 130–130. 1 indexed citations
18.
Dechend, Ralf, Michael Praus, Jeanette Schulz‐Menger, et al.. (1994). Effects of low-molecular weight and high-molecular weight heparin on the intrinsic and extrinsic endogenous fibrinolytic system. Fibrinolysis and Proteolysis. 8. 71–74. 1 indexed citations
19.
Sinha, Pranav, Michael Praus, Eckart Köttgen, Elisabetta Gianazza, & Pier Giorgio Righetti. (1990). Two-dimensional maps in the most extended (pH 2.5–11) immobilized ph gradient interval. Journal of Biochemical and Biophysical Methods. 21(2). 173–179. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Judit Mihaly Breakdown of academic impact, for papers by P Tijburg Breakdown of academic impact, for papers by Alexandre C. Zago Breakdown of academic impact, for papers by Gimbrone Ma Breakdown of academic impact, for papers by C Klein-Soyer Breakdown of academic impact, for papers by Shuchong Pan Breakdown of academic impact, for papers by Karim Harhouri Breakdown of academic impact, for papers by Daniel Yacoub Breakdown of academic impact, for papers by Servé Olieslagers Breakdown of academic impact, for papers by Harlan N. Bradford
Rankless by CCL
2026